180
In a recent study conducted at the University of Georgia (UGA), researchers have raised questions about the effectiveness of a new Alzheimer's drug, suggesting that it may not deliver noticeable benefits as initially hoped.
The drug in question has been the subject of significant attention and expectations as a potential breakthrough in Alzheimer's treatment. However, the findings from the UGA study cast doubt on its ability to provide the anticipated advantages for individuals suffering from the debilitating neurodegenerative disease.
Thomas Cage has more.
Alzheimer's disease, characterized by progressive cognitive decline and memory loss, has been. . .
